Would you invest? MIT-founded Oculo is building the first quantitative brain health platform for the individual. Based on 4 years of research on the correlation between ocular markers and cognitive output, Oculo provides the consumer with actionable brain metrics akin to the physical metrics we see via Oura, Whoop, and Apple Watch, all with zero hardware involved. We estimate a core TAM of over $5B+ annually for Oculo, with material upside.